Skip to main content
SpringerLink
Log in

Clostridium difficile as a cause of acute diarrhea: a prospective study in a tertiary care center

  • Original Article
  • Published:
Indian Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Introduction

Clostridium difficile-associated diarrhea (CDAD) is an increasing problem. Recent reports suggest presence of community acquired CDAD (CA CDAD). Studies in India have shown varied results.

Aims

The following are the aims of this study: (a) the prevalence of CDAD and CA CDAD in patients with acute diarrhea; (b) the incremental yield of second stool sample for the diagnosis of C. difficile infection (CDI); and (c) the risk factors for CDI.

Patients and Methods

Patients with acute diarrhea (<4 weeks) between April 2009 and December 2010 had two stool sample tested for C. difficile toxin (CDT) by enzyme-linked immunofluorescent assay. Demographic, clinical data, risk factors, clinical course, complications, treatment, and response were noted.

Results

Of 150 patients (mean age, 47.3 years; 76 males), 12 (8 %) had their first stool sample positive for CDT. Two patients (1.3 %) had community acquired CDI. The study group was compared with 138 patients (“control group”, stool samples negative for CDT). Compared to the controls, the study group were more likely to have had intensive care unit (ICU) stay (p = 0.018) and tube feeding (p = 0.035). Eleven patients were treated with metronidazole. One patient did not respond to metronidazole and was treated with vancomycin. No patient developed complications of CDAD.

Conclusions

The prevalence of CDAD in our population was 8 % and of CA CDAD was 1.3 %. There was no advantage of testing two samples. ICU stay and tube feeding were major risk factors for the CDAD. Metronidazole was an effective first-line therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin-producing Clostridia. N Engl J Med. 1978;298:531–4.

    Article  PubMed  CAS  Google Scholar 

  2. Barbut F, Corthier G, Charpak Y, et al. Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study. Arch Intern Med. 1996;156:1449–54.

    Article  PubMed  CAS  Google Scholar 

  3. Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med. 2002;346:334–9.

    Article  PubMed  Google Scholar 

  4. Wilcox MH, Mooney L, Bendall R, Settle CD, Fawley WN. A case–control study of community-associated Clostridium difficile infection. J Antimicrob Chemother. 2008;62:388–96.

    Article  PubMed  CAS  Google Scholar 

  5. Dial S, Kezouh A, Dascal A, Barkun A, Suissa S. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ. 2008;179:767–72.

    PubMed  Google Scholar 

  6. Dhawan B, Chaudhry R, Sharma N. Incidence of Clostridium difficile infection: a prospective study in an Indian hospital. J Hosp Infect. 1999;43:275–80.

    Article  PubMed  CAS  Google Scholar 

  7. Vaishnavi C, Kochhar R, Bhasin DK, Thapa BR, Singh K. Detection of Clostridium difficile toxin by an indigenously developed latex agglutination assay. Trop Gastroenterol. 1999;20:33–5.

    PubMed  CAS  Google Scholar 

  8. Vaishnavi C, Bhasin D, Kochhar R, Singh K. Clostridium difficile toxin and faecal lactoferrin assays in adult patients. Microbes Infect. 2000;2:1827–30.

    Article  PubMed  CAS  Google Scholar 

  9. Vaishnavi C, Thapa BR, Thennarasu K, Singh K. Faecal lactoferrin assay as an adjunct to Clostridium difficile diarrhoea. Indian J Pathol Microbiol. 2002;45:69–73.

    PubMed  Google Scholar 

  10. Gogate A, De A, Nanivadekar R, et al. Diagnostic role of stool culture & toxin detection in antibiotic associated diarrhoea due to Clostridium difficile in children. Indian J Med Res. 2005;122:518–24.

    PubMed  CAS  Google Scholar 

  11. Dutta P, Mitra U, Rasaily R, et al. Prospective study of nosocomial enteric infections in a pediatric hospital. Calcutta Indian Pediatr. 1993;30:187–94.

    CAS  Google Scholar 

  12. Niyogi SK, Bhattacharya SK, Dutta P, et al. Prevalence of Clostridium difficile in hospitalised patients with acute diarrhoea in Calcutta. J Diarrhoeal Dis Res. 1991;9:16–9.

    PubMed  CAS  Google Scholar 

  13. Chaudhry R, Joshy L, Kumar L, Dhawan B. Changing pattern of Clostridium difficile associated diarrhoea in a tertiary care hospital: a 5 year retrospective study. Indian J Med Res. 2008;127:377–82.

    PubMed  Google Scholar 

  14. Katyal R, Vaishnavi C, Singh K. Faecal excretion of brush border membrane enzymes in patients with Clostridium difficile diarrhoea. Indian J Med Microbiol. 2002;20:178–82.

    PubMed  CAS  Google Scholar 

  15. Gupta U, Yadav RN. Clostridium difficile in hospital patients. Indian J Med Res. 1985;82:398–401.

    PubMed  CAS  Google Scholar 

  16. Bhattacharya MK, Niyogi SK, Rasaily R, et al. Clinical manifestation of Clostridium difficile enteritis in Calcutta. J Assoc Physicians India. 1991;39:683–4.

    PubMed  CAS  Google Scholar 

  17. Ayyagiri ASP, Venkateshwarlu, Mehta S, Agarwal K. Prevalence of Clostridium difficile in pseudomembranous and antibiotic-associated Colitis in North India. J Diarrhoeal Dis Res. 1986;4:157–60.

    Google Scholar 

  18. Ingle M, Deshmukh A, Desai D, et al. Prevalence and clinical course of Clostridium difficile infection in a tertiary-care hospital: a retrospective analysis. Indian J Gastroenterol. 2011;30:89–93.

    Article  PubMed  Google Scholar 

  19. Bauer MP, Goorhuis A, Koster T, et al. Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage—two case reports with review of the changing epidemiology of Clostridium difficile-associated diarrhoea. Neth J Med. 2008;66:207–11.

    PubMed  CAS  Google Scholar 

  20. Manabe YC, Vinetz JM, Moore RD, Merz C, Charache P, Bartlett JG. Clostridium difficile colitis: an efficient clinical approach to diagnosis. Ann Intern Med. 1995;123:835–40.

    Article  PubMed  CAS  Google Scholar 

  21. Borek AP, Aird DZ, Carroll KC. Frequency of sample submission for optimal utilization of the cell culture cytotoxicity assay for detection of Clostridium difficile toxin. J Clin Microbiol. 2005;43:2994–5.

    Article  PubMed  CAS  Google Scholar 

  22. Bignardi GE. Risk factors for Clostridium difficile infection. J Hosp Infect. 1998;40:1–15.

    Article  PubMed  CAS  Google Scholar 

  23. Manian FA, Meyer L. CDAD rates. Infect Control Hosp Epidemiol. 1995;16:63–5.

    Article  PubMed  CAS  Google Scholar 

  24. Johnson S, Gerding DN. Clostridium difficile-associated diarrhea. Clin Infect Dis. 1998;26:1027–34. quiz 35–6.

    Article  PubMed  CAS  Google Scholar 

  25. Rotimi VO, Mokaddas EM, Jamal WY, Verghese TL, El-Din K, Junaid TA. Hospital-acquired Clostridium difficile infection amongst ICU and burn patients in Kuwait. Med Princ Pract. 2002;11:23–8.

    Article  PubMed  CAS  Google Scholar 

  26. Pepin J, Saheb N, Coulombe MA, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis. 2005;41:1254–60.

    Article  PubMed  CAS  Google Scholar 

  27. Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ. Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis. 2007;45:1543–9.

    Article  PubMed  Google Scholar 

  28. Cunningham R, Dale B, Undy B, Gaunt N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect. 2003;54:243–5.

    Article  PubMed  CAS  Google Scholar 

  29. Asha NJ, Tompkins D, Wilcox MH. Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus. J Clin Microbiol. 2006;44:2785–91.

    Article  PubMed  CAS  Google Scholar 

  30. Rolfe RD. Role of volatile fatty acids in colonization resistance to Clostridium difficile. Infect Immun. 1984;45:185–91.

    PubMed  CAS  Google Scholar 

  31. Thurn J, Crossley K, Gerdts A, Maki M, Johnson J. Enteral hyperalimentation as a source of nosocomial infection. J Hosp Infect. 1990;15:203–17.

    Article  PubMed  CAS  Google Scholar 

  32. Bliss DZ, Johnson S, Savik K, Clabots CR, Willard K, Gerding DN. Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding. Ann Intern Med. 1998;129:1012–9.

    Article  PubMed  CAS  Google Scholar 

  33. May T, Mackie RI, Fahey GC Jr, Cremin JC, Garleb KA. Effect of fiber source on short-chain fatty acid production and on the growth and toxin production by Clostridium difficile. Scand J Gastroenterol. 1994;29:916–22.

    Article  PubMed  CAS  Google Scholar 

  34. Wenisch C, Parschalk B, Hasenhundl M, Hirschl AM, Graninger W. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis. 1996;22:813–8.

    Article  PubMed  CAS  Google Scholar 

  35. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis. 2007;45:302–7.

    Article  PubMed  CAS  Google Scholar 

  36. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431–55.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The Research Department of P D Hinduja National Hospital and Medical Research Centre funded the project.

Author information

Authors and Affiliations

  1. Division of Gastroenterology, P D Hinduja National Hospital and Medical Research Center, Veer Savarkar Marg, Mahim West, Mumbai, 400 016, India

    Meghraj Ingle, Abhijit Deshmukh, Devendra Desai, Philip Abraham, Anand Joshi & Tarun Gupta

  2. Division of Microbiology, P D Hinduja National Hospital and Medical Research Center, Veer Savarkar Marg, Mahim West, Mumbai, 400 016, India

    Camilla Rodrigues

Authors
  1. Meghraj Ingle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abhijit Deshmukh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Devendra Desai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Philip Abraham
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Anand Joshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tarun Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Camilla Rodrigues
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Devendra Desai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ingle, M., Deshmukh, A., Desai, D. et al. Clostridium difficile as a cause of acute diarrhea: a prospective study in a tertiary care center. Indian J Gastroenterol 32, 179–183 (2013). https://doi.org/10.1007/s12664-013-0303-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12664-013-0303-8

Keywords

Search

Navigation